Methods For Identifying, Diagnosing, And Predicting Survival of Lymphomas Read more about Methods For Identifying, Diagnosing, And Predicting Survival of Lymphomas US Application 60/500,377Filed on 2003-09-03
IMMJNOGENIC PEPTIDES OF XAGE-1 Read more about IMMJNOGENIC PEPTIDES OF XAGE-1 US Application 60/529,025Filed on 2003-12-12
Immunogenic Peptides And Peptide Derivatives For The Treatment of Prostate And Breast Cancer Treatment Read more about Immunogenic Peptides And Peptide Derivatives For The Treatment of Prostate And Breast Cancer Treatment US Application 60/476,467Filed on 2003-06-05
Method for Ex-Vivo Selection and Expansion of Stimulus-Responding Primary Cells Using Selective Reversible Immortalization Read more about Method for Ex-Vivo Selection and Expansion of Stimulus-Responding Primary Cells Using Selective Reversible Immortalization US Application 60/528,244Filed on 2003-12-09
Protection Against Vertical Transmission Of Pathogenic Infections Read more about Protection Against Vertical Transmission Of Pathogenic Infections US Application 60/472,983Filed on 2003-05-22
Potent Combinations of mRNA Transport Elements Read more about Potent Combinations of mRNA Transport Elements US Application 60/471,988Filed on 2003-05-19
Catalytic Domains Of Beta(1,4)-Galactosyltransferase I Having Altered Donor And Acceptor Specificiites, Domains, That Promote In Vitro Protein Folding, And Methods For Their Use Read more about Catalytic Domains Of Beta(1,4)-Galactosyltransferase I Having Altered Donor And Acceptor Specificiites, Domains, That Promote In Vitro Protein Folding, And Methods For Their Use US Application 60/450,250Filed on 2003-02-25
High Throughput Screening for Cancer Genes Read more about High Throughput Screening for Cancer Genes US Application 60/466,089Filed on 2003-04-28
Compositions and Methods for Detecting Abnormal Cell Proliferation (Semaphorin Application) Read more about Compositions and Methods for Detecting Abnormal Cell Proliferation (Semaphorin Application) US Application 60/466,154Filed on 2003-04-28
Eosinophil-derived neurotoxin is immunostimulant Read more about Eosinophil-derived neurotoxin is immunostimulant US Application 60/466,796Filed on 2003-04-29